| Robert L Giuntoli Ii, MD | |
|
440 E Marshall St Ste 101, West Chester, PA 19380-5414 | |
| (610) 738-2500 | |
| (610) 738-2540 |
| Full Name | Robert L Giuntoli Ii |
|---|---|
| Gender | Male |
| Speciality | Gynecological Oncology |
| Experience | 30 Years |
| Location | 440 E Marshall St Ste 101, West Chester, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295772515 | NPI | - | NPPES |
| 402873200 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | MD419097 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Medicine Home Health | Bala cynwyd, PA | Home health agency |
| Chester County Hospital | West chester, PA | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Penn - Medical Group | 6204730955 | 3031 |
News Archive
Florida Governor Rick Scott said he has whittled down a corporate tax-relief plan compared with what he sought last year because of a ballooning deficit driven by health-care spending. "Medicaid is growing way faster than we thought," the former hospital executive said yesterday. ... Florida, which closed a $3.8 billion budget gap for fiscal 2012, is facing another of as much as $2.3 billion next year.
Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.
Research presented today at the 31st Annual meeting of the Society for Maternal-Fetal Medicine (SMFM) ― The Pregnancy Meeting™ has found that three proteins known as XIAP, BID, and Bcl-2 are responsible in part for the success of progesterone treatments in the prevention of preterm labor. They may also play an important role in triggering normal labor.
The FDA approval clears the way for Bertek to market APOKYN and provides a new therapy for "off" episodes, one of the most debilitating aspects suffered by patients with Parkinson's disease.
A research team led by St. Jude Children's Research Hospital immunologists has discovered how a set of proteins delays the "executioner" machinery that kills damaged or infected cells in a process called necroptosis.
› Verified 7 days ago
| Entity Name | Clinical Care Associates Of The University Of Pennsylvania Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972682995 PECOS PAC ID: 4688588866 Enrollment ID: O20031113000301 |
News Archive
Florida Governor Rick Scott said he has whittled down a corporate tax-relief plan compared with what he sought last year because of a ballooning deficit driven by health-care spending. "Medicaid is growing way faster than we thought," the former hospital executive said yesterday. ... Florida, which closed a $3.8 billion budget gap for fiscal 2012, is facing another of as much as $2.3 billion next year.
Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.
Research presented today at the 31st Annual meeting of the Society for Maternal-Fetal Medicine (SMFM) ― The Pregnancy Meeting™ has found that three proteins known as XIAP, BID, and Bcl-2 are responsible in part for the success of progesterone treatments in the prevention of preterm labor. They may also play an important role in triggering normal labor.
The FDA approval clears the way for Bertek to market APOKYN and provides a new therapy for "off" episodes, one of the most debilitating aspects suffered by patients with Parkinson's disease.
A research team led by St. Jude Children's Research Hospital immunologists has discovered how a set of proteins delays the "executioner" machinery that kills damaged or infected cells in a process called necroptosis.
› Verified 7 days ago
| Entity Name | Lancaster General Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952392383 PECOS PAC ID: 0941103683 Enrollment ID: O20040309000916 |
News Archive
Florida Governor Rick Scott said he has whittled down a corporate tax-relief plan compared with what he sought last year because of a ballooning deficit driven by health-care spending. "Medicaid is growing way faster than we thought," the former hospital executive said yesterday. ... Florida, which closed a $3.8 billion budget gap for fiscal 2012, is facing another of as much as $2.3 billion next year.
Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.
Research presented today at the 31st Annual meeting of the Society for Maternal-Fetal Medicine (SMFM) ― The Pregnancy Meeting™ has found that three proteins known as XIAP, BID, and Bcl-2 are responsible in part for the success of progesterone treatments in the prevention of preterm labor. They may also play an important role in triggering normal labor.
The FDA approval clears the way for Bertek to market APOKYN and provides a new therapy for "off" episodes, one of the most debilitating aspects suffered by patients with Parkinson's disease.
A research team led by St. Jude Children's Research Hospital immunologists has discovered how a set of proteins delays the "executioner" machinery that kills damaged or infected cells in a process called necroptosis.
› Verified 7 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
Florida Governor Rick Scott said he has whittled down a corporate tax-relief plan compared with what he sought last year because of a ballooning deficit driven by health-care spending. "Medicaid is growing way faster than we thought," the former hospital executive said yesterday. ... Florida, which closed a $3.8 billion budget gap for fiscal 2012, is facing another of as much as $2.3 billion next year.
Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.
Research presented today at the 31st Annual meeting of the Society for Maternal-Fetal Medicine (SMFM) ― The Pregnancy Meeting™ has found that three proteins known as XIAP, BID, and Bcl-2 are responsible in part for the success of progesterone treatments in the prevention of preterm labor. They may also play an important role in triggering normal labor.
The FDA approval clears the way for Bertek to market APOKYN and provides a new therapy for "off" episodes, one of the most debilitating aspects suffered by patients with Parkinson's disease.
A research team led by St. Jude Children's Research Hospital immunologists has discovered how a set of proteins delays the "executioner" machinery that kills damaged or infected cells in a process called necroptosis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert L Giuntoli Ii, MD 440 E Marshall St Ste 101, West Chester, PA 19380-5414 Ph: (610) 738-2500 | Robert L Giuntoli Ii, MD 440 E Marshall St Ste 101, West Chester, PA 19380-5414 Ph: (610) 738-2500 |
News Archive
Florida Governor Rick Scott said he has whittled down a corporate tax-relief plan compared with what he sought last year because of a ballooning deficit driven by health-care spending. "Medicaid is growing way faster than we thought," the former hospital executive said yesterday. ... Florida, which closed a $3.8 billion budget gap for fiscal 2012, is facing another of as much as $2.3 billion next year.
Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.
Research presented today at the 31st Annual meeting of the Society for Maternal-Fetal Medicine (SMFM) ― The Pregnancy Meeting™ has found that three proteins known as XIAP, BID, and Bcl-2 are responsible in part for the success of progesterone treatments in the prevention of preterm labor. They may also play an important role in triggering normal labor.
The FDA approval clears the way for Bertek to market APOKYN and provides a new therapy for "off" episodes, one of the most debilitating aspects suffered by patients with Parkinson's disease.
A research team led by St. Jude Children's Research Hospital immunologists has discovered how a set of proteins delays the "executioner" machinery that kills damaged or infected cells in a process called necroptosis.
› Verified 7 days ago
Richard J Mansfield, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Rd, Bldg. D, Suite 600, West Chester, PA 19380 Phone: 610-692-3434 Fax: 610-692-9005 | |
William R Atkins, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 915 Old Fern Hill Rd, Bldg D Suite 600, West Chester, PA 19380 Phone: 610-692-3434 Fax: 610-692-9005 | |
Jennifer Beauchamp Akins, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Rd, Bldg. D, Suite 600, West Chester, PA 19380 Phone: 610-692-3434 Fax: 610-692-9005 | |
Melissa L Delaney, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 606 E Marshall St, Suite 205, West Chester, PA 19380 Phone: 610-429-9101 Fax: 610-429-9105 | |
Dianne D Hotmer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Rd., Bldg D, Suite 600, West Chester, PA 19380 Phone: 610-692-3434 Fax: 610-692-9005 | |
Dr. Sara Shaw Nicholas, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 780 E Market St Ste 105, West Chester, PA 19382 Phone: 610-649-9021 Fax: 484-266-7352 |